Amneal Pharmaceuticals to Acquire Kashiv BioSciences in Deal Valued at Up to $1.1 Billion

Law firms and who they assisted: - Simpson Thacher & Bartlett represented Amneal Pharmaceuticals, Inc. in the announced acquisition of Kashiv BioSciences, LLC. (No counsel for Kashiv was identified in the release.) Transaction summary: - Amneal will acquire Kashiv in a deal with consideration of $375 million in cash, $375 million in Amneal stock, up to $350 million of potential regulatory milestone payments, and potential royalties tied to certain commercial milestones. The transaction is expected to close in the second half of 2026, subject to Amneal shareholder approval, regulatory approvals and customary closing conditions. Amneal is a Bridgewater, New Jersey–headquartered diversified global biopharmaceutical company with a portfolio of about 300 complex generic, specialty and biosimilar medicines (delivering more than 160 million prescriptions annually, primarily in the U.S.). Kashiv is a vertically integrated biopharmaceutical company with commercial and advanced clinical-stage assets and is among the few U.S.-based companies to both manufacture and receive marketing authorization for multiple biosimilars. Lawyers who participated (practice area as stated in the release; seniority not specified): - Jakob Rendtorff — Mergers & Acquisitions (M&A) - Benjamin Bodurian — M&A - Dan (Daniel) Kim — M&A - Derrick Ray — M&A - Daniel Song — M&A - Andrés (M. Andres) Cruz — M&A - Richard Fenyes — Corporate - Vanessa Burrows — Healthcare - Alison Peters — Healthcare - Jacob (Jacob Madden) Madden — Healthcare - Andrew Purcell — Tax - Shareef Salfity — Tax - Jamin Koslowe — Executive Compensation & Employee Benefits - Ashlie Lawton — Executive Compensation & Employee Benefits - Josh (Joshua) Goldman — Executive Compensation & Employee Benefits - Marie Gesellschap — Executive Compensation & Employee Benefits - Alysha Sekhon — Intellectual Property - Christian Bond — Intellectual Property - Karen Hsu Kelley (Karen Kelley) — Public Company Advisory Practice - Brandon Adoni — Public Company Advisory Practice - Mark Skerry — Foreign Direct Investment (FDI) - Austin Lowe — FDI - Feven Yohannes — FDI - Peter Guryan — Antitrust - Allison Davido — Antitrust - Carleigh Rodriguez — Environmental - Erin Magoffie — Environmental - Krista McManus — Real Estate - Abram Ellis — Regulatory - Christine Tillema — Regulatory - Brian Japari — Regulatory - Steven DeLott — Insurance - Leah Malone — Sustainability & ESG - Chayla Sherrod — Sustainability & ESG (Note: the press release listed the lawyers and their practice groups but did not indicate individual seniority or specific titles.)

Menu

Amneal Pharmaceuticals to Acquire Kashiv BioSciences in Deal Valued at Up to $1.1 Billion

Read the full story

Menu

Amneal Pharmaceuticals to Acquire Kashiv BioSciences in Deal Valued at Up to $1.1 Billion

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads